RSV, Flu and COVID

Have you heard of the ‘quad-demic’? It’s possible you or someone you know is a victim of it. Around the country and in ...
After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely ...
The 30-day risk of death during the 2022-2023 season was 1.0% for COVID-19 compared with 0.7% for both influenza and RSV, and 0.9% for COVID versus 0.7% for both flu and RSV during the ...
Cases of influenza continue to soar across Canada, meanwhile rates of respiratory syncytial virus, or RSV, and COVID-19 are ...